AI capability developments, regulatory frameworks, investment, and the governance contest over artificial intelligence. Published every Friday.
Frontier labs Anthropic and OpenAI are simultaneously pivoting toward AI-for-science as a competitive differentiator, intensifying dual-use biosecurity governance gaps faster than existing frameworks
Read briefing →Frontier labs are vertically integrating into custom silicon, shifting compute control from chip vendors to capital-rich labs and concentrating both capability and governance leverage.
Read briefing →The US has established export-control authority as a precedent for capability-based control over deployed frontier models, converting trade-security tooling into a direct governance lever.
Read briefing →The US has established export-control authority as a precedent for capability-based control over deployed frontier models, converting trade-security tooling into a direct governance lever.
Read briefing →The US government-ordered recall of Anthropic frontier models establishes a precedent that executive national-security authority can directly suspend deployed commercial frontier models.
Read briefing →Export-control authorities have been demonstrated to reach live deployed model access, not just chips and weights, expanding state power over frontier AI.
Read briefing →US export-control authority has become a direct enforcement lever over deployed commercial frontier models, bypassing AI-specific law.
Read briefing →Anthropic's dual-model structure (Fable 5 + Mythos 5) represents a structural shift in how frontier labs manage dual-use capability at release — capability gating is now a product-level feature, not a
Read briefing →Transatlantic regulatory divergence creates forum-shopping opportunities for labs. US labs can avoid EU AI Act obligations by serving EU markets from US infrastructure, while EU labs face dual complia
Read briefing →The US voluntary review mechanism creates a precedent for government visibility into frontier model capabilities without binding enforcement, while the EU Scientific Panel has explicit authority to ad
Read briefing →